Behind the Mystery
A specialized, recurring segment devoted to rare and genetic diseases, Behind the Mystery highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. We clarify the often-complex issues by offering easy-to-understand explanations from top experts in the field. Our goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies, while giving voices to the patients, families, and advocates affected via our national television platform.
The challenge with IgA nephropathy is that most patients don't actually know they have the disease, and most are diagnosed by chance.
In the United States, sickle cell disease affects an estimated 100,000 people. Patients with severe sickle cell have a very poor quality of life, with frequent pain episodes and trips to the hospital.
Learn about how the gut can play a role in serious kidney disease. Plus, what you need to know about sickle cell anemia.
Novocure®, a global oncology company, is working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, tumor treating fields.
Learning more about two diseases that affect the brain: glioblastoma and schizophrenia.
Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.
Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.
Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.
Glioblastoma (GBM) is rare brain tumor that is difficult to treat and has a poor prognosis.